organophosphonates has been researched along with Hemorrhagic Fever, Ebola in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, J; Kupferschmidt, K | 2 |
| Nau, JY | 1 |
| Bavari, S; Cardile, AP; Mayers, DL | 1 |
| Bekerman, E; Einav, S | 1 |
| Florescu, DF; Hewlett, AL; Kalil, AC; Schuh, AJ; Smith, PW; Stroher, U; Uyeki, TM | 1 |
| Lang, T | 1 |
| Blondiaux, J; Haque, A; Hober, D | 1 |
| Albariño, C; Dyall, J; Flint, M; Foster, S; Hensley, LE; Lanier, ER; McMullan, LK; Nichol, ST; Olinger, GG; Sethna, P; Spiropoulou, CF | 1 |
| Cohen, J; Enserink, M | 1 |
| Horby, P; Lang, T; Olliaro, P; Whitehead, J | 1 |
| Antierens, A; Carson, G; Castle, L; Ciglenecki, I; Dunning, J; Grove, J; Horby, PW; Howell-Jones, R; Kanapathipillai, R; Kennedy, SB; Lang, T; Olliaro, P; Pardinaz-Solis, R; Scott, J; Whitehead, J | 1 |
2 review(s) available for organophosphonates and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
Current status of chemically synthesized inhibitors of Ebola virus.
Topics: Adenine; Adenosine; Amides; Antiviral Agents; Cytosine; Drug Discovery; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Organophosphonates; Patents as Topic; Purine Nucleosides; Pyrazines; Pyrrolidines | 2014 |
Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks.
Topics: Amides; Amidines; Androstenes; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antiviral Agents; Benzofurans; Cytosine; Disease Models, Animal; Disease Outbreaks; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Immune Sera; Organophosphonates; Pyrazines; RNA, Small Interfering; Stilbenes; Virus Replication | 2015 |
1 trial(s) available for organophosphonates and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
Experimental Treatment of Ebola Virus Disease with Brincidofovir.
Topics: Adult; Antiviral Agents; Cytosine; Ebolavirus; Female; Hemorrhagic Fever, Ebola; Humans; Liberia; Male; Middle Aged; Organophosphonates; Treatment Outcome; Young Adult | 2016 |
9 other study(ies) available for organophosphonates and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
A dose of reality.
Topics: Antibodies, Viral; Antiviral Agents; Cytosine; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Organophosphonates; Randomized Controlled Trials as Topic; Serum; Therapies, Investigational | 2014 |
[Ebola: three experimental clinical trials directed by MSF].
Topics: Africa, Western; Amides; Anti-Infective Agents; Clinical Trials as Topic; Cytosine; France; Health Services Accessibility; Hemorrhagic Fever, Ebola; Humans; International Cooperation; Organophosphonates; Pyrazines; Societies, Medical | 2014 |
Infectious diseases. Ebola drug trials lurch ahead.
Topics: Amides; Antibodies, Monoclonal; Antiviral Agents; Clinical Trials as Topic; Cytosine; Disease Outbreaks; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Organophosphonates; Pyrazines | 2015 |
Infectious disease. Combating emerging viral threats.
Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses | 2015 |
Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease.
Topics: Adult; Africa, Western; Alanine Transaminase; Antibodies, Viral; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; Cytosine; Hemorrhagic Fever, Ebola; Humans; Immunization, Passive; Immunoglobulin G; Immunoglobulin M; Leukocyte Count; Male; Organophosphonates; Plasma; Platelet Count; Randomized Controlled Trials as Topic; RNA, Viral; Treatment Outcome; Viral Load | 2015 |
Ebola: Embed research in outbreak response.
Topics: Adult; Biomedical Research; Child; Clinical Trials as Topic; Cooperative Behavior; Cytosine; Disaster Planning; Disease Outbreaks; Hemorrhagic Fever, Ebola; Humans; Information Dissemination; Liberia; Organophosphonates; Time Factors; Treatment Outcome; World Health Organization | 2015 |
The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Chlorocebus aethiops; Cidofovir; Cytosine; Drug Evaluation, Preclinical; Ebolavirus; HeLa Cells; Hemorrhagic Fever, Ebola; Human Umbilical Vein Endothelial Cells; Humans; Lipids; Male; Organophosphonates; Structure-Activity Relationship; Vero Cells; Virus Replication | 2016 |
INFECTIOUS DISEASE. As Ebola epidemic draws to a close, a thin scientific harvest.
Topics: Africa, Western; Antiviral Agents; Clinical Trials as Topic; Cytosine; Ebola Vaccines; Ebolavirus; Epidemics; Global Health; Hemorrhagic Fever, Ebola; Humans; Organophosphonates; World Health Organization | 2016 |
Trial design for evaluating novel treatments during an outbreak of an infectious disease.
Topics: Antiviral Agents; Clinical Protocols; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cytosine; Disease Outbreaks; Hemorrhagic Fever, Ebola; Humans; Liberia; Organophosphonates; Randomized Controlled Trials as Topic; Research Design; Sierra Leone; Survival Rate; Treatment Outcome | 2016 |